Ultomiris 300 mg/30 mL concentrate for solution for infusion
RAV-IgA
Approved small_molecule active
Quick answer
Ultomiris 300 mg/30 mL concentrate for solution for infusion for IgA nephropathy is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- IgA nephropathy
- Phase
- Approved
- Modality
- small_molecule
- Status
- active